Sinopharm: its subsidiary obtained overseas registration certificate for API

Technology, Healthcare, Financials Dec 14, 2021 04:19 PM (GMT+8) · EqualOcean

Financial Associated Press, Dec. 14, Sinopharm announced that its wholly-owned subsidiary Sinopharm Rongsheng potassium chloride injection (10ml: 1.5g) obtained the notice of approval for drug supplement application and approved to increase the specification of 10ml: 1.5g. Its wholly-owned subsidiary Sinopharm Wichita obtained the registration certificate of lipoic acid API issued by the Ministry of health and family welfare of India and the Ministry of food and drug safety of South Korea respectively.

This text is a result of machine translation.

Related companies：

China Southern Power Grid

Briefing Mar 21, 2025 05:14 PM · Technology

Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May

Briefing Oct 27, 2023 08:24 AM · Financials | Consumer Staples

Anjoy Foods Q3 Net Profit Totaled CNY 386 million, with an Impressive YoY Increase of 63.75%

In-depth

Financials, Communication

Chinese Education Goes Global: Capturing a Trillion-Dollar Market

A TikTok filter challenge called "Mandarin Fruit Voices" has gone viral. Essentially a straightforward Mandarin learning game with crude animations, minimalist gameplay, and fruit-based pronunciation exercises drawn from early childhood education materials, it has nonetheless captivated international users. For those who once struggled with English, the long-held dream of a world united by Chinese now appears increasingly within reach.

Mar 27, 2025 06:55 PM

Briefing Oct 27, 2023 08:23 AM · Technology | Automotive

Sunwoda Electronics Q3 Net Profit Up 15.74% YoY

Briefing Oct 20, 2023 06:03 PM · Technology

China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model